2. Academic Validation
  3. Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis

Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis

  • Arch Biochem Biophys. 2023 Sep 1:745:109720. doi: 10.1016/j.abb.2023.109720.
Gui Wang 1,  Yamei Qiao 2,  Yunyan Zhao 3,  Yuanyuan Song 4,  Mengyang Li 5,  Min Jin 6,  Dong Yang 7,  Jing Yin 8,  Junwen Li 9,  Weili Liu 10
Affiliations

Affiliations

  • 1 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: 18790678933@163.com.
  • 2 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: qiaoyamei9393@163.com.
  • 3 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: z1334173263@126.com.
  • 4 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: syyeva95@163.com.
  • 5 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: ywz11245968@163.com.
  • 6 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: jinminzh@126.com.
  • 7 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: yangd8611@163.com.
  • 8 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: yjzhych@sohu.com.
  • 9 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: Junwen9999@hotmail.com.
  • 10 Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: liuweili-002@163.com.
PMID: 37611353 DOI: 10.1016/j.abb.2023.109720
Abstract

Beauvericin is a world-spread mycotoxin isolated from the traditional Chinese medicine, Bombyx batryticatus (BB), which has been widely used to treat various neoplastic diseases. This study investigated the anti-hepatocellular carcinoma (HCC) activity of beauvericin and its potential mechanism. In this study, H22-bearing mice were intraperitoneally injected with 3, 5, 7 mg/kg of beauvericin once per-week over a three-week period. TUNEL staining determined the extent of tumor Apoptosis induced by beauvericin. ELISA kits detected the level of IL-2, Perforin, and TNF-α, IFN-γ level in the serum. H22 hepatoma cells were exposed to beauvericin (5, 10, and 20 μmol/L) to investigate the underlying pathway. CCK-8 assay was used to observe the influence of beauvericin on the growth of H22 cells. Flow cytometry was used to detect the cell Apoptosis and ROS level. Western blotting was performed to detect apoptotic and PI3K/Akt pathway protein production. The results showed that beauvericin could remarkably inhibit the growth of HCC in mice, combined with elevated TNF-α and IL-2. In vitro, beauvericin significantly promoted the generation of ROS, up-regulated Bax/Bcl-2 ratio and cleaved caspase-9, cleaved Caspase-3 levels, down-regulated p-PI3K/PI3K ratio, p-AKT/Akt ratio, promoted the Apoptosis of H22 cells, and inhibited the growth of H22 cells. Remarkably, treatment with PI3K/Akt Activator (740Y-P and SC79) could prevent beauvericin-induced H22 cell Apoptosis. These findings collectively indicate that beauvericin inhibits HCC growth by inducing Apoptosis via the PI3K/Akt pathway.

Keywords

Apoptosis; Beauvericin; Hepatocellular carcinoma; PI3K/AKT pathway.

Figures
Products